{{drugbox
| Verifiedfields = changed
| Watchedfields = changed
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = LM19JT6G5K
| verifiedrevid = 408712002
| IUPAC_name        = Methyl (2''S''-''cis'')-7-chloro-6,7,8-trideoxy-6<nowiki>[[</nowiki>(4-ethyl-2-piperidinyl)carbonyl]amino]-1-thio-<small>L</small>-threo-Î±-<small>D</small>-galacto-octopyranoside
| image             = Pirlimycin structure.svg
| alt               = Structural formula
| image2            = Pirlimycin molecule spacefill.png
| alt2              = Space-filling model of pirlimycin molecule

| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number        = 79548-73-5
| CAS_supplemental  = 
| ATCvet            = yes
| ATC_prefix        = J51
| ATC_suffix        = FF90
| ATC_supplemental  = 
| PubChem           = 
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 138508
| smiles = CC[C@@H]1CCN[C@@H](C1)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C17H31ClN2O5S/c1-4-9-5-6-19-10(7-9)16(24)20-11(8(2)18)15-13(22)12(21)14(23)17(25-15)26-3/h8-15,17,19,21-23H,4-7H2,1-3H3,(H,20,24)/t8-,9+,10-,11+,12-,13+,14+,15+,17+/m0/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = HBJOXQRURQPDEX-MHXMMLMNSA-N

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank          = 
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1652611
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08391
| chemical_formula  = 
| C=17 | H=31 | Cl=1 | N=2 | O=5 | S=1
| molecular_weight  = 410.164 g/mol
| bioavailability   = 
| protein_bound     = 
| metabolism        = 
| elimination_half-life = 
| excretion         = 
| pregnancy_AU      =  <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US      =  <!-- A / B            / C / D / X -->
| pregnancy_category=  
| legal_AU =  <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA =  <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK =  <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US =  <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status      = 
| routes_of_administration = Intra[[mammary]]
}}

'''Pirlimycin hydrochloride''' belongs to the [[Lincosamides|lincosamide]] class of [[antimicrobial]]s. Under the trade name '''Pirsue''',<ref>[http://www.pirsue.com/PAHimages/compliance_pdfs/US_EN_PS_compliance.pdf Pirsue Sterile Solution]</ref> it is used in the treatment of [[mastitis]] in [[cattle]].

==Activity==
Pirlimycin is active against [[Gram-positive bacteria]], specifically ''[[Staphylococcus aureus]]'' and [[Coagulase|coagulase negative]] species of ''[[Staphylococcus]]'' and ''[[Streptococcus]]''. It has no activity against [[Gram-negative bacteria]].<ref>[http://www.usp.org/pdf/EN/veterinary/pirlimycin.pdf USP: Pirlimycin]</ref>

==Mechanism of action==
It is [[Bacteriostatic agent|bacteriostatic]] and acts by inhibiting bacterial protein synthesis via binding with the [[50S]] subunit of the ribosome.

==References==
{{Reflist}}

{{Protein synthesis inhibitor antibiotics}}

[[Category:Lincosamide antibiotics]]
[[Category:Veterinary drugs]]


{{antibiotic-stub}}